Premium
Acquired erythropoietic protoporphyria: A systematic review of the literature
Author(s) -
Snast Igor,
Kaftory Ran,
Sherman Shani,
Edel Yonatan,
Hodak Emmilia,
Levi Assi,
Lapidoth Moshe
Publication year - 2020
Publication title -
photodermatology, photoimmunology and photomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.736
H-Index - 60
eISSN - 1600-0781
pISSN - 0905-4383
DOI - 10.1111/phpp.12501
Subject(s) - erythropoietic protoporphyria , porphyria , medicine , ferrochelatase , protoporphyrin , disease , dermatology , acute intermittent porphyria , pediatrics , gastroenterology , heme , biochemistry , chemistry , porphyrin , photochemistry , enzyme
Background Erythropoietic protoporphyria (EPP) is a semi‐dominantly inherited porphyria presenting with photosensitivity during early childhood. Acquired EPP has been reported; however, data regarding this rare disorder are scarce. Purpose To evaluate the characteristics of acquired EPP. Methods A comprehensive search of PubMed, Google Scholar, ScienceDirect, and clinicaltrials.gov databases was performed by three reviewers. Studies describing patients with acquired EPP were included. Additionally, we present an index case of a 26‐year‐old patient who acquired clinically and biochemically typical EPP in association with myelodysplastic syndrome (MDS). Results We included 20 case reports describing 20 patients. Most (80%) patients were male of mean age 58 ± 13 years. In all patients, acquired EPP was associated with hematological disease, most commonly MDS (85%) followed by myeloproliferative disease (10%). In 86% of cases, hematological disease led to abnormality or somatic mutation in chromosome 18q (the locus of the ferrochelatase gene). The mean erythrocyte protoporphyrin IX concentration was very high (4286 μg/dL). Most (90%) patients presented with photosensitivity, 20% experienced blistering, and 25% presented with hepatic insufficiency, both uncommon in EPP. In 55% of patients, hematological disease was diagnosed after occurrence of cutaneous symptoms. Beta‐carotene led to partial control of symptoms in 5 patients and resolution in another patient. Azacitidine treatment of MDS led to resolution of cutaneous symptoms in three patients. Conclusion We present the distinct features of acquired EPP and highlight that any patient presenting with new‐onset photosensitivity, irrespective of age should be evaluated for porphyria.